Akebia Therapeutics
AKBA
#6513
Rank
S$0.73 B
Marketcap
$2.80
Share price
3.38%
Change (1 day)
51.40%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -S$92.57 Million

According to Akebia Therapeutics's latest financial reports the company's current earnings are S$0.16 Billion. a decrease over its 2023 earnings that were of -S$68.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -S$90.96 Million33.68%
2023 -S$68.05 Million-45.12%
2022 -S$0.13 Billion-66.55%
2021 -S$0.38 Billion-26.24%
2020 -S$0.51 Billion33.94%
2019 -S$0.38 Billion66.52%
2018 -S$0.23 Billion123.53%
2017 -S$0.11 Billion-43.34%
2016 -S$0.18 Billion123.58%
2015 -S$79.57 Million63.95%
2014 -S$48.53 Million181.24%
2013 -S$17.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
S$6.03 B-6,740.25%๐Ÿ‡บ๐Ÿ‡ธ USA
S$17.87 B-19,751.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$22.85 B-25,228.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA